<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Autoimmune neuropathies &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/autoimmune-neuropathies/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 12 Oct 2025 09:47:59 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Autoimmune neuropathies &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Evolution of Primary Autoimmune Neuropathies Explained</title>
		<link>https://bioengineer.org/evolution-of-primary-autoimmune-neuropathies-explained/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 12 Oct 2025 09:47:28 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Autoimmune neuropathies]]></category>
		<category><![CDATA[chronic inflammatory demyelinating polyradiculoneuropathy]]></category>
		<category><![CDATA[complement inhibitors]]></category>
		<category><![CDATA[efgartigimod]]></category>
		<category><![CDATA[Guillain-Barré syndrome]]></category>
		<guid isPermaLink="false">https://bioengineer.org/evolution-of-primary-autoimmune-neuropathies-explained/</guid>

					<description><![CDATA[Autoimmune neuropathies are a group of rare and disabling disorders, with Guillain–Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) standing out as the most notable examples. These conditions are characterized by the immune system erroneously targeting the peripheral nerves, leading to weakness, sensory disturbances, and in severe cases, paralysis. The complexities around diagnosing and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">279507</post-id>	</item>
	</channel>
</rss>
